# Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/final-3-year-results-of-the-dasatinib-discontinuation-trial-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masaya Okada,Jun Imagawa,Hideo Tanaka,Hirohisa Nakamae,Masayuki Hino,Kazunori Murai,Yoji Ishida,Takashi Kumagai,Seiichi Sato,Kazuteru Ohashi,Hisashi Sakamaki,Hisashi Wakita,Nobuhiko Uoshima,Yasunori Nakagawa,Yosuke Minami,Masahiro Ogasawara,Tomoharu Takeoka,Hiroshi Akasaka,Takahiko Utsumi,Naokuni Uike,Tsutomu Sato,Sachiko Ando,Kensuke Usuki,S Mizuta,Satoshi Hashino,Tetsuhiko Nomura,Masato Shikami,H Fukutani,Yokiko Ohe,Hiroshi Kosugi,Hirohiko Shibayama,Yasuhiro Maeda,Toshihiro Fukushima,Hirohito Yamazaki,Kazuo Tsubaki,Toshimasa Kukita,Yoko Adachi,Toshiki Nataduka,Hiroto Sakoda,Hisayuki Yokoyama,Takahiro Okamoto,Yukari Shirasugi,Yasushi Onishi,Masaharu Nohgawa,Satoshi Yoshihara,Satoshi Morita,Junichi Sakamoto,Shinya Kimura |
| Citations | 117 |
| DOI | 10.1016/j.clml.2018.03.004 |
| Fields | Agricultural and Biological Sciences,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.clml.2018.03.004 |
| OpenAlex ID | https://openalex.org/W2792113531 |
| PMID | 29610029 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Kensuke Usuki](https://scholariq.org/researchers/kensuke-usuki/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Garlic and Onion Studies](https://scholariq.org/topics/garlic-and-onion-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.